|
HS Code |
703171 |
| Generic Name | Levetiracetam |
| Brand Names | Keppra, Spritam |
| Drug Class | Antiepileptic (anticonvulsant) |
| Chemical Formula | C8H14N2O2 |
| Route Of Administration | Oral, Intravenous |
| Indications | Seizure disorders (epilepsy), partial onset seizures, myoclonic seizures, tonic-clonic seizures |
| Mechanism Of Action | Modulates synaptic neurotransmitter release by binding to SV2A protein in the brain |
| Common Side Effects | Drowsiness, dizziness, fatigue, irritability, headache |
| Contraindications | Hypersensitivity to levetiracetam |
| Pregnancy Category | Category C |
| Half Life | 6-8 hours |
| Protein Binding | Less than 10% |
| Metabolism | Minimal hepatic metabolism |
| Excretion | Primarily renal |
As an accredited Levetiracetam factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Levetiracetam 500 mg tablets are packaged in a white box containing 30 film-coated tablets, each blister strip safely sealed. |
| Shipping | Levetiracetam is shipped in tightly sealed, properly labeled containers to prevent contamination and ensure stability. It is transported at controlled room temperature and protected from light and moisture. Shipping follows regulatory guidelines for pharmaceuticals, with appropriate documentation and safety measures to ensure compliance and product integrity during transit. |
| Storage | Levetiracetam should be stored at room temperature, typically between 15°C and 30°C (59°F to 86°F), away from moisture, heat, and direct light. Keep the medication in its original container, tightly closed, and out of reach of children and pets. Avoid storing it in bathrooms to prevent exposure to excess humidity. Dispose of expired or unused medication properly. |
|
Purity 99%: Levetiracetam with a purity of 99% is used in the formulation of injectable antiepileptic medications, where high purity ensures reduced risk of adverse reactions and consistent therapeutic outcomes. Melting Point 112°C: Levetiracetam with a melting point of 112°C is used in tablet manufacturing processes, where precise melting characteristics enable uniform drug dispersion and consistent dosage forms. Molecular Weight 170.21 g/mol: Levetiracetam with a molecular weight of 170.21 g/mol is used in pharmacokinetic studies, where accurate molecular profiling enhances dose calculation and metabolic tracing. Particle Size <50 μm: Levetiracetam with a particle size below 50 μm is used in oral suspension formulations, where fine particle size improves solubility and bioavailability for pediatric and geriatric patients. Stability Temperature up to 40°C: Levetiracetam stable up to 40°C is used in global distribution of finished dosage forms, where enhanced stability minimizes degradation and maintains efficacy during transport and storage. Water Solubility 100 mg/mL: Levetiracetam with water solubility of 100 mg/mL is used in intravenous formulations, where high solubility ensures rapid onset of action in emergency seizure management. Assay ≥98%: Levetiracetam with assay values of at least 98% is used in controlled-release tablet production, where high assay guarantees precise therapeutic dosing and regulatory compliance. Residual Solvents <0.1%: Levetiracetam with residual solvents under 0.1% is used in parenteral drug manufacturing, where minimal solvent content ensures patient safety and meets pharmaceutical quality standards. Enantiomeric Purity >98%: Levetiracetam with enantiomeric purity above 98% is used in advanced neurological research, where high stereochemical purity eliminates variability in bioactivity and clinical study outcomes. Bulk Density 0.45 g/cm³: Levetiracetam with a bulk density of 0.45 g/cm³ is used in high-speed tablet compression, where optimized density improves processing efficiency and tablet uniformity. |
Competitive Levetiracetam prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Imagine the challenge for families living with the shadow of seizures. Every day can come with uncertainty, not knowing if a loved one will be affected at work, in the classroom, or behind the wheel. Medication like Levetiracetam provides a real lifeline for people who want reliability and, just as important, straightforward daily routines. Having worked with people managing neurological disorders, I have seen the ripple effects a medication can have—going far beyond chemistry into daily hopes and fears.
Levetiracetam earned its spot on clinic shelves for good reason. It shows up every day for patients facing epileptic seizures, including both adults and children. The way it works stands out. Unlike older anti-epileptic drugs, it targets a specific protein on nerve cells, which influences how signals travel and dampens excess electrical activity. This approach helps block the rapid-fire impulses that trigger seizures, without a laundry list of side effects that weigh folks down or slow them up.
The model families most often see comes in tablet, liquid, and even injectable forms, sold in a range of strengths. Many appreciate picking from 250 mg, 500 mg, 750 mg, and 1000 mg tablets; sometimes, children or those with difficulties swallowing turn to the oral solution instead. Hospitals rely on intravenous forms for urgent needs or postoperative care. There’s no mystery at the pharmacy—dosing remains consistent with medical instruction and rarely strays from the twice-daily rhythm most people find easy to remember.
Spending time in clinics where parents worry about side effects, or where an elderly patient desperately needs a straightforward routine, you pick up on the difference certain medications make. A single pill that lets a person go about their day with fewer interruptions becomes a small freedom. Many I’ve known who took Levetiracetam describe fewer mood swings or foggy-headed mornings compared to days on older medications. They check off doctor’s appointments feeling more in control and less overwhelmed by complex regimes or sudden fatigue.
Some families stick a pillbox on the fridge and move on. Others call in for the syrup for their children, knowing each dose sets the stage for a more predictable day at school. Younger patients and their parents value not worrying about missing a meal, because this medication rarely depends on food intake to work properly. That’s not just a technical benefit—it’s a piece of mental space freed up for actually living rather than always planning.
Let’s talk about real-world experience with side effects. Patients and families usually fear having to choose between stopping seizures and losing themselves to mood changes or trouble concentrating. Levetiracetam tends to rate low for those kinds of problems, especially when compared to the heavy hitters from previous generations. There’s always a tradeoff with any prescription, but reports of weight gain, drowsiness, or foggy thinking turn up less often in my experience. Occasionally, some folks notice mild dizziness, headache, or irritation; in rare cases, it can spark agitation or changes in mood that prompt a switch. Honest communication with a doctor usually helps spot these issues early and sort them out before they get in the way.
One thing I’ve observed again and again is the relief among patients who don’t have to chase bloodwork every month or keep changing dose due to concerns about their liver. Levetiracetam travels through the kidneys, not the liver, which means many people with other health issues find it easier to tolerate and safer over time. I recall patients with compromised liver function who stuck with seizure control simply because this medication made it possible, and it brought real peace of mind for both doctors and families alike.
In the crowded world of anti-epileptic drugs, each one carves out its place by what it asks of a patient. Levetiracetam requires fewer dietary or medication restrictions, doesn’t set off complicated interactions, and usually delivers reliable blood levels without a complicated titration schedule. That shows up in the smile of a college student who is relieved not to worry about tons of drug interactions. It shows up in working parents who no longer check their watch every few hours in case a dose window slips by.
For many people, having fewer restrictions on lifestyle means getting to say yes more often: to travel, to spontaneous plans, and to jobs that demand flexible hours. Parents don’t have to explain to a teacher why their child is too groggy to read aloud in class, because the medication supports steady cognitive function for most. The kid who once sat out at recess because of dizziness finds they’re no longer as sidelined. These are small wins that add up in big ways.
Medical guidelines back up much of what gets seen day-to-day. Nearly every reputable neurology cooperation in the world includes Levetiracetam in their recommendations for partial-onset and generalized seizures. The World Health Organization lists it as an essential medicine, making it a mainstay both in top-tier urban hospitals and smaller clinics worldwide.
Long-term studies continue reassuring patients and doctors. They show that Levetiracetam maintains seizure control in a broad swath of the epilepsy community, including those who failed therapy with other drugs. As for drug interactions, Levetiracetam keeps things refreshingly simple: other common prescriptions, such as blood pressure medications, rarely create conflicts. I’ve heard from pharmacists who have an easier time counseling patients simply because the chances of cross-reactions stay so low.
Anxiety about serious side effects or toxicity turns up less often than years past, and the low risk of affecting the liver or causing blood disorders means routine medical monitoring doesn’t become its own burden. That translates to lower cost, fewer doctor visits, and overall less stress in managing a lifelong condition.
Much of what makes Levetiracetam different becomes clear when you look back at older anticonvulsants. Drugs like carbamazepine, valproic acid, and phenytoin all bring effective seizure control but often ask patients to carry extra burdens. They may trigger weight gain, shakes, vision changes, or require constant adjustments based on diet, other prescriptions, or even pregnancy status.
Valproic acid, for example, stands out for broad action but brings heightened risks during pregnancy and a stronger link to liver problems. Phenytoin, used widely in past decades, asks for regular bloodwork and can present tougher side effects if levels drift too high. Carbamazepine interacts with dozens of other meds and sometimes causes skin reactions or low blood counts. Everyone winds up trading off stability for possible complications, and too often, the patient experience gets lost in that balance.
Levetiracetam arrived as a clear improvement for many. The dosing stays steady and seldom needs tinkering. Elderly adults juggling multiple prescriptions can often add it without fear of causing an upset in their other treatments. For kids, the lack of sedating or weight-promoting effects makes it a go-to first line in pediatric clinics. Young adults, eager to drive or hold down work, gain more predictable cognition and fewer embarrassing fumbles on the job.
Talking about medications in terms of chemistry and side effects only scratches the surface. What matters more for most families is whether a drug lets them live life with some measure of normalcy. Levetiracetam removes some everyday hassles, which makes a difference for those struggling to stay independent. It’s especially relevant in areas with shaky access to healthcare. If a doctor or pharmacist recognizes a prescription and it’s easy to obtain, adherence improves and outcomes get better.
Pricing can prove tricky in some health systems. Fortunately, generic options have hit the market, keeping Levetiracetam within reach for a broader population. Often, patients tell me they feel empowered by a choice that balances effectiveness with affordability. For people facing lifelong therapy, cost impacts every year, so insurance coverage and low-cost generic programs provide real relief. If any medication promises stability while easing the financial load, it stands a better chance of sticking around for those who need it most.
No seizure medication comes without some hurdles. Levetiracetam’s unique side effects, though less common, can include irritability or mood swings in a subset of patients. Open communication with healthcare providers becomes key. Many clinics build in regular mental health check-ins, offering counseling or dosage adjustments that set people up for long-term use.
Medication reminders—phone alerts, pill organizers, visual schedules—help families stick to routines. Home visits from nurses or pharmacists, especially for people newer to seizure management, close the gap for folks nervous about missing doses. For the rare cases where this medication triggers tough psychological effects, smart referral systems can direct patients to mental health support early and keep setbacks to a minimum.
For those puzzled by new symptoms or in need of support, patient advocacy groups have stepped up. Online forums and local support groups become a lifeline, where people exchange tips and learn how peers manage any rough patches. Multilingual instructions and coaching ensure non-native speakers or people with reading challenges can stick with treatment confidently.
Epilepsy often hides in the background, so the drive for better, safer medications shouldn’t slow down. Levetiracetam might not work for every patient or every kind of seizure—certain types, or rare syndromes, call for other medications or combination therapy. There’s still much to learn about fine-tuning doses for special cases, including those who are pregnant, managing kidney disease, or recovering from brain surgery.
Health equity plays a major role. While many people in cities or with strong insurance embrace Levetiracetam, those in isolated areas or without insurance face tougher access. Community health programs have started tackling this gap by offering education, free clinics, or medication assistance. Better education for school staff and employers about seizure action plans helps reduce the social stigma and keeps kids in class and adults in the workforce. Clear public messaging focused on facts—reminding folks that epilepsy needn’t mean isolation—smooths the way for more inclusive communities.
Ongoing research aims to sort out which genes or traits predict better responses to certain medications, including Levetiracetam. As science marches forward, we’ll see improvements in how medications get customized to each person, reducing trial-and-error and speeding up the path toward relief. Study of digital reminders and telemedicine has moved rapidly. Many patients now get help from a smartphone app, text check-ins with nurses, or virtual access for follow-up visits. This technology removes barriers once faced by folks living hundreds of miles from the nearest neurologist or who juggle complicated family lives.
Advocacy pushes still matter—helping lawmakers and health agencies understand the real value of affordable, reliable anti-epileptic drugs for both kids and adults. Levetiracetam has forced the issue by proving that fewer rules, less red tape, and more flexibility in daily life pay off for families and the wider health system.
Doctors, pharmacists, and nurses see firsthand the value of a medication that adapts to changing patient needs. A willingness to adjust doses, swap between pill and liquid, or switch to an injectable version keeps people out of the hospital and at home with family. Developing clear protocols for managing side effects—realistic, with patient input—goes much further than relying only on numbers from clinical trials.
Pharmacies and health systems also learn from feedback. Patients who can easily pick up refills, have questions answered quickly, and get help navigating insurance hurdles stick with the plan much more reliably. Education, transparency, and genuine partnership in care outperform any shiny marketing brochure.
People living with epilepsy ask for straightforward solutions. The promise offered by Levetiracetam comes down to this: greater freedom, more predictability, better quality of life. As larger studies confirm its safety and real-world experience continues to back up those numbers, it gains an even stronger footing in epilepsy care. Families, clinics, teachers, and employers all benefit when a treatment empowers patients rather than tying them to a long list of restrictions.
No one system or medication ever solves every concern. What stands out with Levetiracetam is a track record built not just on data, but on lived experience. Access, patient comfort, fewer barriers, and a clear voice in treatment—these make a real difference for people who want normalcy alongside their prescription. Practical solutions, patient-centered care, and ongoing support make all the difference for those learning to live with epilepsy every day.